Related Experiment Video
Updated: Jul 14, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate
Longchuan Bai1, Juanita L Merchant
1Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Histone deacetylase inhibitors (HDACi) induce growth arrest and differentiation, particularly in the colon where they are potential chemotherapeutic agents. A key mediator of HDACi action is the cyclin dependent kinase (CDK) inhibitor p21(waf1). HDACi treatment of colonic cells promotes the formation of an ATM/ZBP-89/p300 complex on p21(waf1) proximal promoter, and this multi-molecular complex plays an important role in HDACi induction of p21(waf1) expression in vitro and mucosal protection in vivo. Here we found that ZBP-89 is phosphorylated by ATM kinase in vitro and in vivo. Disruption of the ATM phosphorylation motif (202)SQ within the zinc finger domain of ZBP-89 attenuated its ability to enhance p21(waf1) activation by butyrate. Moreover, disruption of the ATM phosphorylation site abrogated the ability of ZBP-89 to potentiate butyrate induction of endogenous p21(waf1) expression. These results demonstrate that ATM phosphorylation of ZBP-89 contributes to HDACi induction of p21(waf1) gene expression.
Insights
Histone deacetylase inhibitors (HDACi) promote colon cancer cell growth arrest. ATM kinase-mediated phosphorylation of ZBP-89 is crucial for HDACi-induced p21(waf1) gene expression and therapeutic effects.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Histone deacetylase inhibitors (HDACi) are investigated as chemotherapeutics, particularly for colon cancer.
- HDACi induce cell growth arrest and differentiation, mediated partly by the cyclin-dependent kinase (CDK) inhibitor p21(waf1).
- A complex involving ATM, ZBP-89, and p300 is known to regulate p21(waf1) expression following HDACi treatment.
Purpose of the Study:
- To investigate the role of ATM kinase in the phosphorylation of ZBP-89.
- To determine if ATM-mediated phosphorylation of ZBP-89 is essential for HDACi-induced p21(waf1) expression.
- To elucidate the contribution of ZBP-89 phosphorylation to the mechanism of HDACi action in colonic cells.
Main Methods:
- In vitro and in vivo phosphorylation assays of ZBP-89 by ATM kinase.
- Site-directed mutagenesis to disrupt the ATM phosphorylation motif (202)SQ in ZBP-89.
- Assays to evaluate the effect of ZBP-89 phosphorylation status on p21(waf1) activation by butyrate (an HDACi).
- Measurement of endogenous p21(waf1) expression following butyrate treatment in cells expressing wild-type or mutated ZBP-89.
Main Results:
- ZBP-89 was confirmed to be phosphorylated by ATM kinase both in vitro and in vivo.
- Disruption of the ATM phosphorylation site (202)SQ in ZBP-89 significantly reduced its ability to enhance butyrate-induced p21(waf1) activation.
- The mutated ZBP-89 lacking the functional ATM phosphorylation site failed to potentiate the induction of endogenous p21(waf1) expression by butyrate.
Conclusions:
- ATM kinase phosphorylates ZBP-89, a critical step in the signaling pathway.
- ATM-mediated phosphorylation of ZBP-89 is essential for the potentiation of p21(waf1) gene expression by HDAC inhibitors like butyrate.
- This phosphorylation event is a key mechanism contributing to the therapeutic effects of HDAC inhibitors in colon cells.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Anaphase Promoting Complex
Negative Regulator Molecules